adjuvant vaccine

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

909 documents for adjuvant vaccine

- AVANT Announces Vaccine Adjuvant Licenses with 3M.
Access to enabling TLR adjuvants to advance novel antibody-based vaccine platform NEEDHAM, Mass. -- Celldex Therapeutics, Inc. (a wholly-owned subsi...
- Business Wire
- June 11, 2008
- Juvaris BioTherapeutics' Vaccine Adjuvant, JVRS-100, Generates Superior T-Cell Mediated Immune Responses to Influenza in Clinical Trial.
Data to be Presented at the 12(th) Annual Conference on Vaccine Research BURLINGAME, Calif. -- Juvaris BioTherapeutics, Inc., a biotechnology compan...
- Business Wire
- April 27, 2009
- Therapeutic Vaccine Company Inovio Biomedical Demonstrates Utility of Its Electroporation Delivery Technology as Potent Vaccine Adjuvant.
Published in Journal of Virology, Study Shows DNA Vaccine Delivered Via Electroporation Induces Recruitment of Immune Cells to the Site of Administrat...
- Business Wire
- April 09, 2008

- ImmuneRegen(R) BioSciences to Provide Adjuvant to DynPort Vaccine Company for Development of an Inactivated Vaccine against Venezuelan Equine Encephalitis Virus.
SCOTTSDALE, Ariz. -- ImmuneRegen BioSciences, a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBO), will provide its adjuvant cand...
- Business Wire
- April 30, 2008
- Novel Intranasal Nanoemulsion Vaccine Adjuvant Also Effective by Subcutaneous and Intramuscular Injection.
Significant Protection against H5N1 Flu Strain Demonstrated ANN ARBOR, Mich. -- NanoBio Corporation today announced positive results from studies in...
- Business Wire
- December 02, 2009
- BioSante Pharmaceuticals Announces Positive Bird Flu Results Using Proprietary Vaccine Adjuvant in Pre-Clinical Study.
LINCOLNSHIRE, Ill. -- BioSante Pharmaceuticals, Inc. (Amex:BPA) today announced positive results of a dose ranging pre-clinical study demonstrating th...
- Business Wire
- January 30, 2007
- Avantogen Receives Milestone Payment from Endocyte for GPI Vaccine Adjuvant; Company Also Receives European Patent and Commences Preclinical Studies for Herpes Vaccine.
SAN DIEGO & SYDNEY, Australia -- Avantogen, Ltd. (ASX:ACU), formerly Australian Cancer Technology, today announced that Endocyte, Inc. will pay its fi...
- Business Wire
- June 15, 2005
- Juvaris BioTherapeutics Initiates Phase 2 Study of Influenza Vaccine Adjuvant in Elderly Population.
Adjuvant Designed to Improve Effectiveness of Existing Seasonal Influenza Vaccine BURLINGAME, Calif. -- Juvaris BioTherapeutics, Inc., a biotechnolo...
- Business Wire
- November 02, 2009
- Colby Pharmaceutical Company Announces Publication of JVRS-100 use as Potent Immune Activating Adjuvant in Combination with H5N1 Influenza Vaccine.
SAN JOSE, Calif. -- Colby Pharmaceutical Company (CPC) today announced publication of new results showing that a single dose of JVRS-100 adjuvanted H5...
- Business Wire
- January 09, 2012
- Avantogen's Vaccine Adjuvant GPI-0100 Licensed by Hawaii Biotech Inc.; GPI-0100 Is Licensed Initially for West Nile Virus and Dengue Fever Vaccines.
SYDNEY, Australia & SAN DIEGO & HONOLULU -- Avantogen Limited, (formerly Australian Cancer Technology Limited "AustCancer")(ASX:ACU), and Hawaii Biote...
- Business Wire
- October 13, 2005